OraSure Technologies, Inc. (NASDAQ:OSUR)
CAPS Rating:
The Company develops, manufactures and markets oral specimen collection devices using its proprietary oral fluid technologies, diagnostic products including in vitro diagnostic tests, and other medical devices.
RSS Headlines
Fool UK
Recs
OraSure Technologies Inc. has a "point-of-care" test for HIV. I expect it will become a standard test at the emergency room and possibly other locations/situations involving contact between patient/professional. Of course, the 'big sell' is distribution OTC. As that is some time in the future, Mr.Market is currently offering a nice buy-in price.